Two-stage revision shoulder prosthesis vs. permanent articulating antibiotic spacer in the treatment of periprosthetic shoulder infections

Orthop Traumatol Surg Res. 2019 Apr;105(2):237-240. doi: 10.1016/j.otsr.2018.10.010. Epub 2018 Nov 27.

Abstract

Introduction: Periprosthetic shoulder infections (PSIs) represent a serious complication following shoulder arthroplasty. No consensus exists regarding the optimal option. We conducted a retrospective case-control study to compare the outcomes of 2-stage revision shoulder arthroplasty and those of definitive articulating antibiotic spacer implantation with regards to eradication of the infection, improvement of pain and shoulder function.

Materials and methods: Thirty patients treated for an infected shoulder arthroplasty were retrospectively reviewed after a mean follow-up of 8 years (range, 2-10 years). Nineteen underwent definitive articulating antibiotic spacer implantation and 11 underwent 2-stage revision arthroplasty. Mean age at surgery was 68.8 years. Assessment included Constant-Murley score, visual analog scale pain score, objective examination, patient subjective satisfaction score as well as standard radiographs.

Results: At the most recent follow-up, none of the patients had clinical or radiographic signs suggesting recurrent infection. Most patients reported satisfying subjective and objective outcomes. Follow-up examination showed significant improvement of all variables compared to preoperative values (p<0.001). Radiographs did not show progressive radiolucent lines or change in the position of the functional spacer. No statistically significant differences were reported between the two groups concerning Constant-Murley and VAS scores, while average forward flexion and abduction were significantly higher in patients undergoing 2-stage revision surgery.

Conclusions: Both surgical procedures provided infection eradication and satisfying subjective functional outcomes. Functional results were superior in patients treated with revision shoulder prosthesis, although a higher rate of complication was reported in this cohort of patients, thus suggesting the use of permanent spacer in high-risk or low-demanding elderly patients.

Level of evidence: III, Retrospective case-control study.

Keywords: Antibiotic spacer; Infected shoulder arthroplasty; Periprosthetic shoulder infection; Revision arthroplasty.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology*
  • Arthritis, Infectious / diagnosis
  • Arthritis, Infectious / physiopathology
  • Arthritis, Infectious / surgery*
  • Arthroplasty / adverse effects*
  • Case-Control Studies
  • Coated Materials, Biocompatible*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Design
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / physiopathology
  • Prosthesis-Related Infections / surgery*
  • Radiography
  • Range of Motion, Articular
  • Reoperation / methods
  • Retrospective Studies
  • Shoulder Joint / diagnostic imaging
  • Shoulder Joint / physiopathology
  • Shoulder Joint / surgery
  • Shoulder Prosthesis / adverse effects*

Substances

  • Anti-Bacterial Agents
  • Coated Materials, Biocompatible